central drugs standard control organisation

AstraZeneca gets nod to market cancer drug in India

admin 2025 年 10 月 8 日 No Comments

This marks the first and only antibody drug conjugate in India with a tumour-agnostic indication, representing a significant advancement in precision oncology, the company said.